The genetically heterogeneous Spinocerebellar ataxias (SCAs) are caused by 26 Purkinje neuron dysfunction and degeneration, but their underlying pathological 27 mechanisms remain elusive. The Src family of non-receptor tyrosine kinases (SFK) are 28 essential for nervous system homeostasis and are increasingly implicated in 29 degenerative disease. Here we reveal that the SFK suppressor Missing-in-Metastasis 30 (MTSS1) is an ataxia locus that links multiple SCAs. MTSS1 loss results in increased 31 SFK activity, reduced Purkinje neuron arborization, and low basal firing rates, followed 32 by cell death. Surprisingly, mouse models for SCA1, SCA2, and SCA5 show elevated 33 SFK activity, with SCA1 and SCA2 displaying dramatically reduced MTSS1 protein 34 levels through reduced gene expression and protein translation, respectively. Treatment 35 of each SCA model with a clinically-approved Src inhibitor corrects Purkinje basal firing, 36 and delays ataxia progression in MTSS1 mutants. Our results identify a common SCA 37 therapeutic target and demonstrate a key role for MTSS1/SFK in Purkinje neuron 38 survival and ataxia progression. Significance Statement (120/120) 61 The Src family of non-receptor tyrosine kinases (SFK) are essential for nervous system 62 function, and may contribute to neurodegeneration. Spinocerebellar ataxias (SCAs) are 63 neurodegenerative diseases where Purkinje neurons fire irregularly and degenerate 64 leading to motor problems. We show that the SFK suppressor Missing-in-Metastasis 65 (MTSS1) is an ataxia gene that links multiple SCAs. MTSS1 loss results in increased 66 SFK activity, degenerating Purkinje neurons with low firing rates, and cell death. 67 Surprisingly, mouse models for three different SCAs show elevated SFK activity, with 68 SCA1 and SCA2 models displaying dramatically reduced MTSS1 protein levels. 69 Treatment of each SCA model with SFK inhibitor corrects Purkinje basal firing, and 70 delays ataxia progression in MTSS1 mutants. Our results identify a common link among 71 disparate neurodegenerative diseases.
an antibody specific to the N-terminal IMD domain (30) (Fig 1B) .
149
To our surprise, homozygous MIM EX15 mutants appear normal for cilia dependent 150 processes with no observed instances of holoprosencephaly or polydactyly after multiple 151 generations. Additionally, MIM EX15 mutant males are fertile. Instead, MIM EX15 mutants 152 display a striking and progressive ataxia. To better understand the nature of MIM EX15 153 ataxia, we characterized MIM EX15 mutants using an open field test to evaluate gross 154 motor control. MIM EX15 mutants had reduced velocity (Fig 1C) and rearing behavior ( Fig   155   1D ), consistent with overall movement defects. To uncouple possible motor and 156 behavioral abnormalities we evaluated MIM EX15 mutants with rotarod assay and 157 observed coordination abnormalities in as early as 4 weeks of age (Fig 1E) . Many 158 spinocerebellar ataxias display progressive neurologic phenotypes. To determine 159 whether MIM EX15 animals showed progressive deterioration we employed a composite 160 test measuring gait, grip strength and balance (46) . We found MIM EX15 animals 161 performed consistently worse than controls, with severity increasing with age (Fig 1F) .
162
MIM EX15 heterozygous animals displayed 75% of normal protein levels (SI Appendix, Fig   163   S1C ), giving no overt phenotype.
164
Reduced Mtss1 levels are associated with a variety of cellular phenotypes 165 including reduced presentation of receptors on the cell membrane (47), and altered 166 Purkinje neuron morphology (41, 44) . To determine the basis of the motor abnormalities 167 and to distinguish among these possibilities we performed histological analysis. At 4 168 weeks, MIM EX15 mice are ataxic, yet their cerebella appeared grossly normal with intact 169 granule, Purkinje neuron, and molecular layers. However, MIM EX15 mutants displayed a 170 progressive loss of Purkinje neurons in all cerebellar lobes readily seen by 8 weeks of 171 age ( Fig S1A) . Whereas wild type cerebella contain approximately 8 Purkinje neurons in 172 a 250 μm linear distance, 8-week old mice retained only 25% of wild type, and 36 week 173 MIM EX15 mutants contained only 5% of the total number of Purkinje neurons (Fig 1G) .
174
While ataxia genes can act in many cell types to regulate Purkinje cell function,
175
MTSS1 is highly expressed in Purkinje cells, suggesting it is required in these cells for 176 normal Purkinje cell function and survival. To confirm the Purkinje neuron defects seen in MIM EX15 animals are due to a cell autonomous requirement for Mtss1, we conditionally as the MTSS1 antibody showed high specificity (SI Appendix Fig S1B) as well as dramatically reduced staining for the Golgi body marker Giantin (Fig 2A) . We 197 also observed increased transcript abundance for the early autophagy effector VMP1 198 (53). By 8 weeks of age we could detect increased LC3-II species (Fig 2B, Fig S2C) . Interestingly, we were unable to detect 202 increased Sqstrm1 (p62) transcript or protein levels in MIM EX15 , an autophagocytic 203 adapter protein associated with protein aggregation neurodegenerative disease (54) ( Fig   204   S2B ). MIM EX15 animals displayed increased neuroinflammation shown by increased Aif1 205 transcript levels ( Fig 2D) , a readout of microglial infiltration. MIM EX15 animals also show 206 increased GFAP positive glial infiltration (Fig 2E, 2F , SI Appendix S1A) consistent with 207 reactive astroglyosis. Consistent with signs of autophagocytic cell death and 208 neuroinflammation, we failed to see increased DNA breaks in MIM EX15 Purkinje neurons 209 with TUNEL stain (Fig 2G) . 210 211 thinned molecular layer including SCA2(1), SCA3 (55), that likely reflects reduced 217 Purkinje dendritic volume. Similarly, MIM EX15 mutants showed a 60% reduction in the 218 expansiveness of the dendritic tree ( Fig 3B) and a significant decrease in the number of 219 dendritic spines (Fig 3C) , although no significant difference was detected in spine length 220 ( Fig 3D) or width (Fig 3E) .
221
In dermal fibroblasts and Drosophila border cells MTSS1 functions to locally 222 prevent ectopic Src kinase activity and Mtss1 mutant phenotypes can be rescued by 223 genetically removing Src kinase (28, 29) . To determine if Mtss1 acts similarly in Purkinje 224 neurons we evaluated SFK activity levels in cerebellar lysates from MIM EX15 mutants and 225 found elevated levels of SFK Y416 (Fig 3F) indicative of increased SFK activity. Previous 226 work has shown strong functional interactions between SFK and metabotropic glutamate 227 receptor type I (mGluR1) neurotransmission at parallel fiber synapse (56). To investigate 228 whether MTSS1/SFK modulation of mGluR1 signaling forms the basis of the ataxia, we 229 performed electrophysiological analysis of Purkinje neurons in cerebellar slices from 230 MIM EX15 mice. We evaluated Purkinje neuron response to parallel fiber stimulation using 231 calcium imaging. We found MIM EX15 mutant Purkinje neurons responded with a 232 comparable increase of calcium dependent fluorescence to controls, while adding the 233 mGluR1 antagonist CPCCOEt abolished these responses (Fig 3G) . These data support 234 MTSS1 acting post-synaptically to control Purkinje cell function.
235
Purkinje neurons maintain a cell autonomous tonic firing rate that is essential for 236 their function (57, 58) . Since MIM EX15 Purkinje neurons responded normally to parallel 237 fiber stimulation suggesting normal synaptic transmission, we assayed basal firing rate.
238
Purkinje neuron tonic firing rate is highly sensitive to temperature and may vary slightly 239 between investigators (59). In our assays, wild type cells had a mean firing rate of 240 43±2Hz (n=2 animals, 62 cells), while 4-week old MIM EX15 mutants exhibited a 12±1Hz 241 mean rate (n=2 animals, 55 cells) (Figs 3H, 3I) . Previous studies of SCA mouse models 242 demonstrated reduced tonic firing is a basis for ataxia (1, 3, 5) . Since basal firing is 243 reduced at an age when MIM EX15 mice possess a normal number of Purkinje neurons, our 244 results suggest neuron malfunction rather than loss underlies the initial ataxia phenotype. significantly increased the MIM EX15 basal firing rate from baseline to 29±1Hz (n=2 251 animals, 62 cells). We also observed that dasatinib slightly reduced the wild type basal 252 firing rate to 35±1Hz (n=2 animals, 79 cells). Time course experiments showed the 253 increase in basal firing rate occurred over 5 hours (SI Appendix Fig S3) , consistent with 254 a low concentration, high affinity mechanism of action. Direct modulation of ion channel 255 or mGluR1 activity raises basal firing within minutes (4, 60), suggesting that dasatinib 256 works through a distinct mechanism. To determine whether SFK inhibition ameliorates 257 ataxia in vivo we administered dasatinib directly to the cerebellum via minipumps to 258 overcome poor CNS bioavailability (61). Over 4 weeks, dasatinib treated MIM EX15 mice 259 were protected from disease progression while untreated mice showed progressively 260 worsening rotarod performance (Fig 3J) (n=2 drug, 3 control). These results 261 demonstrate that Src family kinases act downstream of MTSS1 and that SFK inhibitors 262 rescue Mtss1-dependent basal firing rate defects to slow disease progression.
264

Mtss1 is a translation target of ATXN2 265
The slow basal firing and ataxia preceding cell death seen in the MIM EX15 266 mutants resembles that seen in other SCA models such as SCA1, SCA2, and SCA5, 267 prompting us to investigate whether MTSS1/SFK dysregulation occurs in other ataxias.
268
SCA2 is caused by an expansion in the polyglutamine (polyQ) tract of the RNA binding 269 protein ATAXIN-2 (ATXN2) to more than 34 repeats (62) . The exact molecular defects 270 that drive SCA2 pathogenesis remain unclear, as loss of function mice do not 271 recapitulate the SCA2 phenotype (63), while intermediate expansion alleles are 272 associated with increased risk for frontotemporal dementia (64). Atxn2 has an ancestral 273 role in translation control (7, 65), which may be altered with the SCA2 mutation, but the 274 exact targets have yet to be described.
275
MTSS1 protein abundance is heavily regulated by metastasis-associated miRs 276 which bind to the Mtss1 3' untranslated region and reduce steady-state MTSS1 protein 277 levels (66-70) To determine whether MTSS1 protein accumulation is sensitive to Atxn2 278 we examined the ATXN2 Q127 mouse model of SCA2 (1). We found MTSS1 abundance was progressively reduced by 90% at 24 weeks, a level far greater than the 50% 280 reduction in Purkinje neuron marker Calbindin (Fig 4A upper 
band, SI Appendix Fig
basal firing frequency seen in ATXN2 Q127 mice is due to elevated SFK activity.
285
Remarkably, addition of dasatinib to ATXN2 Q127 cerebellar slices restored the basal firing 286 rate from an average of 14±1Hz (n=2 animals, 100 cells) to nearly normal levels of 287 32±2Hz (n=2 animals, 72 cells; Fig 4C, 4D) . As in the MIM EX15 mutants, the firing rate 288 reached maximal effect at 5-6 hours of SFK inhibition (SI Appendix Fig S3) , leading us 289 to conclude that inappropriate SFK activity underlies both the ATXN2 and MTSS1-290 mediated firing phenotype.
291
The convergence of Mtss1 and ATXN2 on SFK activity suggested they work in a 292 common or parallel molecular pathway. To distinguish between these possibilities, we 293 further interrogated MTSS1 protein levels in ATXN2 Q127 cerebella. While we found 294 reduction of MTSS1 protein ( Fig S4A) and RNA in ATXN2 Q127 Purkinje neurons ( Fig   295   S4B ) , we failed to see comparable changes in ATXN2 levels in 4-week old MIM EX15 296 mice (Fig 4E) . Because ATXN2 possesses RNA binding activity, and Mtss1 contains a 297 long 3'UTR, we hypothesized that ATXN2 controls Mtss1 translation in Purkinje neurons.
298
RNA-IP followed by QPCR in cells expressing tagged versions of either WT (ATXN Q22 ) 299 or SCA2 (ATXN2 Q108 ) demonstrated both proteins specifically bound MTSS1 mRNA 300 compared to GAPDH control. (Fig 4F) . Using a luciferase reported fused to the MTSS1 301 3' UTR we were able to map the ATXN2 interacting domain to a central 500bp region 302 that was sufficient for both RNA-protein interaction and translation control (SI Appendix 303 Fig S4C,D) . Furthermore, polyribosome fractionation experiments revealed that 304 pathogenic ATXN2 Q108 was sufficient to block the translation of reporter mRNA fused to 305 the MTSS1 3'UTR shifting the transcript from the polyribosome fractions to a detergent 306 resistant fraction consistent with stress granules (Fig 4G) . These results suggest the 307 pathogenic ATXN2 acts directly as a dominant negative RNA binding protein preventing 308 MTSS1 translation. Notably, we observed MTSS1 abundance is reduced in human SCA 309 patient cerebellum, bolstering the evolutionary conservation of the ATXN2/MTSS1 310 interaction (Fig 4H) . 311 312 SFK inhibition rescues Purkinje neuron firing across SCA vastly different Purkinje neuron mRNA profiles (73). However, the exact targets that 318 drive SCA1 pathogenesis are still being determined. Unlike SCA1 and SCA2, SCA5 is a 319 more pure cerebellar ataxia due to lesions in the structural protein β-III spectrin (13). β-III 320 spectrin directly binds to and controls the cell membrane localization of EAAT4
321
(excitatory amino acid transporter 4), a protein involved in the synaptic clearance of 322 glutamate (12, 74).
323
If SCA1 or SCA5 arises similarly to SCA2 by dysregulation of the MTSS1/SFK 324 cassette, we would expect decreased MTSS1 abundance. Indeed, in the ATXN1 Q82 325 mouse model of SCA1 (75) we observed a 95% decrease in MTSS1 protein abundance 326 (Fig 5A) with only a 50% reduction in calbindin, suggesting the loss of MTSS1 is not 327 solely due to loss of Purkinje neurons.
328
Atxn1 pathogenicity is partially driven by phosphorylation at serine 776 (72),
329
which was unchanged in 4-week old MIM EX15 mice, suggesting MTSS1 is a target of the 330 SCA1 allele (Fig 5B) . Additionally, Mtss1 transcript abundance is reduced at multiple 331 ages in ATXN1 Q8 mice (73) (Fig 5C) . We found treating ATXN1 Q82 slices with dasatinib 332 increased the basal firing rate from a baseline of 15±1Hz (n=3 animals, 21 cells) to 333 23±2Hz (n=3 animals, 21 cells), a level statistically indistinguishable from dasatinib-334 treated controls (Fig 5D) .
335
By contrast, the Sptbn2 knockout model of SCA5 (βIII -/-)(3), showed no change in 336 MTSS1 protein abundance at 3 weeks yet demonstrated a clear increase in SFK Y416 337 phosphorylation (Fig 5E) . We also observe increased basal firing from 25±1Hz (n=2 338 animals, 31 cells) to 30±2Hz (n=3 animals, 43 cells) over a 7-hour period of dasatinib 339 treatment (Fig 5F) . We fail to see changes in β-III spectrin abundance in MIM EX15 mice, 340 and detect a 40% decrease in β-III spectrin levels in 24-week ATXN2 Q127 mice that is 341 likely due to reduced Purkinje neuron dendritic arbor size, correlating with calbindin 342 levels (Fig 5G, 5H) . Together these data suggest that β-III spectrin and MTSS1 may 343 work in parallel, through different mechanisms, to modulate SFK activity (Fig 5I) . were designed for oncology targets and lack potent central nervous system activity.
408
Further, while we provide data for kinase inhibition to suppress MTSS1 loss, we have 409 previously shown that SFK regulation by regulatory receptor tyrosine phosphatases, or 410 deletion of endocytic adapter proteins can also revert the effects of MTSS1 loss. Given 
799
Luciferase reporter assay shows ATXN2 translation is strongly mediated by the 3'UTR, 800 and ATXN2 Q108 allele is sufficient to block activation ns not significant, all other 801 interactions p<0.005. 2way ANOVA finds reporter constructs explain 56% of total 802 variance, differences in response to transfection (pcDNA, ATXN2 Q22 , ATXN2 Q22+Q108 ) 803 between reporter constructs explains 30% of variance, and different response to 804 transfection (pcDNA, ATXN2 Q22 , ATXN2 Q22+Q108 ) within a reporter explain 14% of total 805 variance.
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